Mitochondrial Genetics and Disease Mechanisms

Mitochondria are unique organelles harbouring their own genome, yet relying on extensive coordination with the nuclear genome to maintain cellular bioenergetics and metabolic homeostasis. The mitochondrial genome (mtDNA) encodes core subunits of the oxidative phosphorylation machinery, while nuclear genes direct the import, replication and repair of mtDNA, as well as the assembly of respiratory complexes. Variation in mtDNA copy number and the coexistence of multiple sequence variants within a cell (heteroplasmy) influence the threshold at which mitochondrial dysfunction emerges, contributing to ageing and a spectrum of inherited metabolic and neurodegenerative diseases. In parallel, advances in genome editing have begun to address pathogenic point mutations in mtDNA, offering hope of direct therapeutic intervention. Beyond energy production, mitochondria serve as signalling hubs that integrate metabolic cues, regulate apoptosis and modulate intracellular communication. Disruption of these roles underlies the pleiotropic manifestations of mitochondrial disease, which may present in single organs or involve multiple systems. Understanding the interplay between nuclear and mitochondrial genetic variation, the dynamics of mtDNA maintenance and the mechanisms governing respiratory chain assembly is essential for the development of diagnostic biomarkers and precision therapies in mitochondrial medicine.

Research from Nature Portfolio

Recent studies have revealed how common variants in the nuclear genome shape both the abundance of mtDNA and the dynamics of heteroplasmic mutations across large human cohorts. By analysing whole-genome sequences from hundreds of thousands of individuals, researchers have mapped dozens of nuclear loci that influence mtDNA copy number, identify age-related trajectories of mtDNA decline and uncover novel pathways involved in mtDNA replication and maintenance. These findings illuminate the nuclear genetic architecture that underlies clinical variability in mitochondrial disorders and ageing.

Complementing these insights, the development of mitochondria-targeted base editors has transformed the landscape of potential therapies for mtDNA diseases. Programmable DNA-binding proteins fused to deaminase enzymes achieve precise conversion of single nucleotides at pathogenic sites in patient-derived cells, with strand selectivity and editing efficiencies exceeding 70 per cent. This approach directly corrects deleterious mtDNA variants without reliance on double-strand breaks or guide RNAs, offering a versatile platform for the treatment of inherited mitochondrial disorders.

Mitochondrial Genetics and Disease Mechanisms publication trend

The graph below shows the total number of articles in mitochondrial genetics and disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

mtDNA copy number: The number of mitochondrial genome molecules per cell, which affects respiratory capacity and varies with age and genetic background.

Heteroplasmy: The coexistence of more than one mtDNA sequence within a cell or tissue, influencing disease penetrance and severity.

Oxidative phosphorylation: The process by which mitochondria generate ATP through electron transport and proton gradients across the inner membrane.

Base editing: A genome-editing technique that catalyses direct nucleotide conversions without introducing double-strand breaks, enabling precise correction of point mutations.

Respirasome: A supramolecular assembly of multiple respiratory chain complexes (I, III and IV) thought to facilitate efficient electron transfer and stabilise individual complexes.

References

1. Nuclear genetic control of mtDNA copy number and heteroplasmy in humans. Nature (2023).
2. Mitochondria at the crossroads of health and disease. Cell (2024).
3. Strand-selective base editing of human mitochondrial DNA using mitoBEs. Nature Biotechnology (2023).
4. Preserved respiratory chain capacity and physiology in mice with profoundly reduced levels of mitochondrial respirasomes. Cell Metabolism (2023).
5. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. EMBO Molecular Medicine (2018).